Nalaganje...
VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication
AIM: To investigate the inhibitory effect of VP22 fusion protein-based dominant negative (DN) mutant on Hepatitis Bvrus (HBV) replication. METHODS: Full-length or truncated fragment of VP22 was fused to C terminal of HBV core protein (HBc), and subcloned into pcDNA3.1 (-) vector, yielding eukaryotic...
Shranjeno v:
| izdano v: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2005
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355781/ https://ncbi.nlm.nih.gov/pubmed/16425411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i41.6429 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|